NouvNeu-002

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameNouvNeu-002
Drug Alias NameNouvNeu002NouvNeu-002
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan Ruijian Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Ruijian Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A